Xeris Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.25
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.15
|
0.00
|
0.15
|
100.00%
|
|
2022-12-31
|
-0.15
|
0.00
|
0.15
|
100.00%
|
|
2022-09-30
|
-0.16
|
-0.16
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.23
|
-0.19
|
0.04
|
17.39%
|
|
2022-03-31
|
-0.25
|
-0.25
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.24
|
-0.42
|
-0.18
|
-75.00%
|
|
2021-09-30
|
-0.37
|
-0.39
|
-0.02
|
-5.41%
|
|
2021-06-30
|
-0.30
|
-0.41
|
-0.11
|
-36.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.60
|
|
2021-12-31
|
-1.52
|
|
2020-12-31
|
-2.28
|
|
2019-12-31
|
-4.80
|
|
2018-12-31
|
-9.45
|
|
2017-12-31
|
-9.67
|
|
2016-12-31
|
-2.29
|